Paclitaxel
NDC Package 44567-504-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Paclitaxel is used to treat various types of cancer. Marketed by Wg Critical Care, Llc, this product is identified by NDC 44567-504 and is authorized under FDA application NDA020262.

Identification & Billing

NDC Package Code
44567-504-01
Package Description
1 VIAL, MULTI-DOSE in 1 CARTON / 5 mL in 1 VIAL, MULTI-DOSE
Product Code
44567-504
11-Digit Billing Format
44567050401

Clinical Specifications

Proprietary Name
Paclitaxel
Dosage Form
-
Usage Information
Paclitaxel is used to treat various types of cancer. It is a cancer chemotherapy drug that works by slowing or stopping cancer cell growth.

Regulatory & Marketing

Labeler Name
Wg Critical Care, Llc
FDA Application #
NDA020262
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-11-2013
End Marketing Date
04-30-2022
Listing Expiration
04-30-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 44567-504-01 identifies a specific commercial package of 1 vial, multi-dose in 1 carton / 5 ml in 1 vial, multi-dose of Paclitaxel, labeled by Wg Critical Care, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wg Critical Care, Llc on July 11, 2013. The current certification is valid through April 30, 2022.

What are the primary indications for this medication?

Paclitaxel is used to treat various types of cancer. It is a cancer chemotherapy drug that works by slowing or stopping cancer cell growth.

How is this Wg Critical Care, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 44567050401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
44567-504-01
11-Digit CMS (5-4-2)
44567-0504-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.